Zobrazeno 1 - 10
of 15
pro vyhledávání: '"K. R. Müller-Vahl"'
Dopamine D1 receptor availability in Gilles de la Tourette syndrome (GTS): A C-11-SCH23390 PET study
Autor:
M. Rullmann, D. Gkotsoulias, S. Schmitt, C. Fremer, C. Klages, K. Hartung, A. Bujanow, F. Zientek, K. Messerschmidt, M. Patt, O. Sabri, K. R. Müller-Vahl, H. Möller, H. Barthel
Publikováno v:
61. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
H. G. Müller-Vahl, K. R. Müller-Vahl
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 123:1343-1346
History and clinical findings Two weeks after a mild viral infection a previously healthy 22-year-old woman developed ileus, a severe abnormality of orthostasis, sicca (Sjogren's) syndrome, bilateral miosis and generalized hyphidrosis. Pelvic endosco
Autor:
K. R. Müller-Vahl
Publikováno v:
Der Nervenarzt. 78:264-271
The treatment ofTourette's syndrome is a challenge. Dopamine receptor antagonists are the drugs of first choice for the treatment of tics. Because large controlled trials are lacking, there is no consensus about which of the different neuroleptic dru
Autor:
K. R. Müller-Vahl, L. Schöls, A. Münchau, Christian Gerloff, Thomas Brandt, Hans-Christoph Diener
Dieses Buch enthält den Artikel: Tics und Gilles de la Tourette-Syndrom aus dem Sammelband: Therapie und Verlauf neurologischer Erkrankungen. Das große Referenz- und Facharztbuch zur klinischen Neurologie liegt hiermit unter der Federführung der i
Publikováno v:
Schmerz (Berlin, Germany). 18
Autor:
J C, Möller, B, Tackenberg, M, Heinzel-Gutenbrunner, R, Burmester, W H, Oertel, O, Bandmann, K R, Müller-Vahl
Publikováno v:
European journal of neurology. 15(7)
The cause of Tourette syndrome (TS) is not precisely known, although several lines of evidence point at an involvement of the immune system in its pathogenesis.Here, we report the results of a pilot study investigating frequently analysed lymphocyte
Publikováno v:
Molecular psychiatry. 12(7)
Autor:
K R, Müller-Vahl
Publikováno v:
Der Nervenarzt. 78(3)
The treatment of Tourette's syndrome is a challenge. Dopamine receptor antagonists are the drugs of first choice for the treatment of tics. Because large controlled trials are lacking, there is no consensus about which of the different neuroleptic dr
Publikováno v:
Der Nervenarzt. 76(9)
For about 5,000 years, cannabis has been used as a therapeutic agent. There has been growing interest in the medical use of cannabinoids. This is based on the discovery that cannabinoids act with specific receptors (CB1 and CB2). CB1 receptors are lo
Autor:
S, Johannes, B M, Wieringa, M, Mantey, W, Nager, D, Rada, K R, Müller-Vahl, H M, Emrich, R, Dengler, T F, Münte, D, Dietrich
Publikováno v:
Acta neurologica Scandinavica. 104(1)
The Gilles de la Tourette Syndrome (TS) and Obsessive Compulsive Disorder (OCD) have been shown to display impaired cognitive and motor inhibition. This study investigated inhibitory mechanisms of motor responses in order to expand the understanding